🇺🇸

US SEC Filing Intelligence

· daily

DOE Energy & National Labs Contracts — December 31, 2025

DOE awarded a $1.96B cost-plus award fee contract to nonprofit FERMI FORWARD DISCOVERY GROUP, LLC for Fermi National Accelerator Laboratory (FNAL) management through 2029-12-31, with $595M outlayed to date, signaling stable multi-year R&D funding in physical sciences. This full-and-open competition award to a Chicago-based entity underscores DOE commitment to GOCO operations amid neutral market signals. Investors face execution risks from performance fees and budget exposure, but $7.4M options upside and extension potential offer long-term upside.

1 total filings
· daily

Biodefense & Pandemic Preparedness — December 24, 2025

A single major CDC contract awards McKesson $152.8M obligated (68.4M outlayed) for centralized vaccine distribution, with $8.1B base + options potential through 2029, signaling strong biodefense revenue visibility for McKesson Corp. This underscores sustained HHS/CDC investment in pandemic preparedness infrastructure. Investors should monitor option exercises amid firm-fixed-price execution risks.

1 total filings
· daily

NME Blockbuster Approvals — December 17, 2025

On December 17, 2025, a surge of 94 filings revealed clusters of US SEC 8-Ks dominated by Entry into Material Definitive Agreements (Item 1.01), signaling widespread M&A, financing, or partnership activity across financials, biotech, energy, and REITs, often paired with exhibits lacking disclosed details. Australian ASX filings highlighted routine distributions and mislabeled buy-back updates from blue-chips like CSL, QBE, and Brambles, indicating capital return confidence amid neutral sentiment. Isolated administrations in unknown entities flagged distress, but overall neutral tone with low-medium materiality suggests end-of-period housekeeping rather than seismic shifts; cumulative impact points to potential alpha in undisclosed strategic deals.

38 high priority 55 medium 94 total filings
· daily

USA Corporate Actions — December 17, 2025

The single filing from Gabelli Dividend & Income Trust reveals a governance-focused 8-K on amendments to Articles of Incorporation or Bylaws and a potential fiscal year change, mislabeled under the 'Dividend' event stream with no actual dividend disclosures or quantitative metrics provided. This low-materiality (2/10) neutral development signals routine corporate housekeeping rather than a significant corporate action, carrying limited broader market implications for US equity dividend plays. Institutional investors should note the absence of dividend catalysts, underscoring a quiet period for tracked corporate actions on 2025-12-17 with no cumulative sector momentum evident.

1 medium 1 total filings